Vaccine Research
VaxInnate is touting the results of a Phase I trial for a new seasonal flu vaccine that they say could do away with the need for an annual jab. Report
Scientists in New Zealand are testing a new adjuvant in cancer vaccines that they say appears safe and effective. Report
Nabi Biopharmaceuticals reported positive final results from its Phase II NicVAX (Nicotine Conjugate Vaccine) schedule optimization immunogenicity study to assess the antibody response and safety of a 400 microgram, six dose immunization schedule. Release
A universal vaccination program can protect the entire population from a flu outbreak. Story
Vaxart announced positive efficacy results from preclinical studies of the company's oral avian flu vaccine. Release
Vaccine market
A sudden surge in the number of cases of anaphylactic shock after single vaccines has raised safety concerns in the UK. Story
Some 200 polling places around the U.S. are offering a flu shot on election day. Report